Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds

Zimmer Biomet's (NYSE: ZBH ) stock dropped close to 10% after the company reported soft first quarter results and meaningfully reduce full year earnings guidance. While there are a range of factors impacting Zimmer Biomet's business at the moment, weakness is beingRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achieved ...